Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5743587
[patent_doc_number] => 20060089312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/512213
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 106
[patent_figures_cnt] => 106
[patent_no_of_words] => 26061
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512213 | Smart pro-drugs of serine protease inhibitors | Apr 29, 2003 | Issued |
Array
(
[id] => 7361649
[patent_doc_number] => 20040014657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Use of blood coagulation factor XIII for treating haemophilia A'
[patent_app_type] => new
[patent_app_number] => 10/415424
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2326
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415424 | Use of blood coagulation factor XIII for treating haemophilia A | Apr 28, 2003 | Abandoned |
Array
(
[id] => 6805572
[patent_doc_number] => 20030232966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Thyrotropin-releasing hormone analogues and their therapeutic applications'
[patent_app_type] => new
[patent_app_number] => 10/419538
[patent_app_country] => US
[patent_app_date] => 2003-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11241
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10419538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/419538 | Thyrotropin-releasing hormone analogues and their therapeutic applications | Apr 20, 2003 | Issued |
Array
(
[id] => 7591163
[patent_doc_number] => 07662922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Canola protein isolate compositions'
[patent_app_type] => utility
[patent_app_number] => 10/413371
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13679
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662922.pdf
[firstpage_image] =>[orig_patent_app_number] => 10413371
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/413371 | Canola protein isolate compositions | Apr 14, 2003 | Issued |
Array
(
[id] => 7676954
[patent_doc_number] => 20040152872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Method for modifying a protein structure'
[patent_app_type] => new
[patent_app_number] => 10/398799
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7579
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152872.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398799 | Method for modifying a protein structure | Apr 9, 2003 | Abandoned |
Array
(
[id] => 6874855
[patent_doc_number] => 20030195152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Polymeric conjugates of antitumor agents'
[patent_app_type] => new
[patent_app_number] => 10/333619
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5848
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333619 | Polymeric conjugates of antitumor agents | Apr 9, 2003 | Abandoned |
Array
(
[id] => 6770603
[patent_doc_number] => 20030216543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Insulin purification using simulated moving bed technology'
[patent_app_type] => new
[patent_app_number] => 10/276948
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24798
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276948 | Insulin purification using simulated moving bed technology | Apr 6, 2003 | Abandoned |
Array
(
[id] => 5632240
[patent_doc_number] => 20060148710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Oligopeptides, composition and use thereof as elicitors of the natural defences of plants'
[patent_app_type] => utility
[patent_app_number] => 10/551771
[patent_app_country] => US
[patent_app_date] => 2003-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4695
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551771 | Oligopeptides, composition and use thereof as elicitors of the natural defences of plants | Apr 1, 2003 | Abandoned |
Array
(
[id] => 1017626
[patent_doc_number] => 06890518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-10
[patent_title] => 'Compositions of chemically modified insulin'
[patent_app_type] => utility
[patent_app_number] => 10/405190
[patent_app_country] => US
[patent_app_date] => 2003-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21488
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10405190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/405190 | Compositions of chemically modified insulin | Mar 31, 2003 | Issued |
Array
(
[id] => 7346611
[patent_doc_number] => 20040192611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Peptide antioxidants from soy protein'
[patent_app_type] => new
[patent_app_number] => 10/401131
[patent_app_country] => US
[patent_app_date] => 2003-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6070
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192611.pdf
[firstpage_image] =>[orig_patent_app_number] => 10401131
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/401131 | Peptide antioxidants from soy protein | Mar 27, 2003 | Abandoned |
Array
(
[id] => 7206768
[patent_doc_number] => 20040087527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Methods for treatment of thiol-containing compound deficient conditions'
[patent_app_type] => new
[patent_app_number] => 10/400980
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 27954
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10400980
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/400980 | Methods for treatment of thiol-containing compound deficient conditions | Mar 26, 2003 | Abandoned |
Array
(
[id] => 7199789
[patent_doc_number] => 20050164925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Treatment of gastroparesis'
[patent_app_type] => utility
[patent_app_number] => 10/508762
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8422
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508762 | Treatment of gastroparesis | Mar 26, 2003 | Abandoned |
Array
(
[id] => 5801249
[patent_doc_number] => 20060035810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Regulation of ins(3456)p4 signalling by a reversible kinase phosphatase and methods and compositions related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/508363
[patent_app_country] => US
[patent_app_date] => 2003-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24125
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508363 | Regulation of ins(3456)p4 signalling by a reversible kinase phosphatase and methods and compositions related thereto | Mar 17, 2003 | Abandoned |
Array
(
[id] => 7535220
[patent_doc_number] => 08048846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Protein-silane/siloxane copolymers, their preparation and their use'
[patent_app_type] => utility
[patent_app_number] => 10/388180
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8587
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10388180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/388180 | Protein-silane/siloxane copolymers, their preparation and their use | Mar 13, 2003 | Issued |
Array
(
[id] => 7103531
[patent_doc_number] => 20050106257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Microparticles and method for their production'
[patent_app_type] => utility
[patent_app_number] => 10/506952
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6164
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506952 | Microparticles and method for their production | Mar 13, 2003 | Issued |
Array
(
[id] => 996609
[patent_doc_number] => 06914049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'IGF-binding protein-derived peptide or small molecule'
[patent_app_type] => utility
[patent_app_number] => 10/383999
[patent_app_country] => US
[patent_app_date] => 2003-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 37
[patent_no_of_words] => 19217
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10383999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/383999 | IGF-binding protein-derived peptide or small molecule | Mar 6, 2003 | Issued |
Array
(
[id] => 6740718
[patent_doc_number] => 20030158087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases'
[patent_app_type] => new
[patent_app_number] => 10/240324
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3998
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240324 | Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases | Mar 5, 2003 | Abandoned |
Array
(
[id] => 224942
[patent_doc_number] => 07605125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'DNA-binding polyamide drug conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/506085
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 9445
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605125.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506085
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506085 | DNA-binding polyamide drug conjugates | Feb 26, 2003 | Issued |
Array
(
[id] => 856814
[patent_doc_number] => 07375073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth'
[patent_app_type] => utility
[patent_app_number] => 10/375733
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14833
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375733
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375733 | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth | Feb 26, 2003 | Issued |
Array
(
[id] => 435905
[patent_doc_number] => 07262162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system'
[patent_app_type] => utility
[patent_app_number] => 10/373196
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 12036
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10373196
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/373196 | Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system | Feb 25, 2003 | Issued |